0% found this document useful (0 votes)
67 views2 pages

Counterfeit Drugs

The Central Drugs Standard Control Organization (CDSCO) in India defines counterfeit drugs as those that are fraudulently produced or mislabeled, posing serious health risks to consumers. The CDSCO has raised alarms about counterfeit and substandard medicines, urging consumer vigilance and reporting of suspicious drugs. Measures are being taken to combat this issue, including alerts, investigations, and promoting consumer awareness about verifying medicine authenticity.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
67 views2 pages

Counterfeit Drugs

The Central Drugs Standard Control Organization (CDSCO) in India defines counterfeit drugs as those that are fraudulently produced or mislabeled, posing serious health risks to consumers. The CDSCO has raised alarms about counterfeit and substandard medicines, urging consumer vigilance and reporting of suspicious drugs. Measures are being taken to combat this issue, including alerts, investigations, and promoting consumer awareness about verifying medicine authenticity.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

In the context of the Central Drugs Standard Control Organization (CDSCO) in India, a

counterfeit drug is defined as a drug that is fraudulently produced, mislabeled, or deceptively


represented in terms of its identity, composition, or source. This means it is not what it claims
to be and may contain the wrong ingredients, the wrong dosage, or be completely devoid of
the active ingredient.

 Spurious or Imitation Drugs:

These are drugs manufactured with the intention of deceiving the buyer by mimicking a
well-known brand, potentially without containing the active ingredients or containing
adulterants.

 Counterfeit Drugs:

According to WHO, counterfeit drugs are those deliberately and fraudulently mislabeled
with respect to identity, composition, and/or source.

 Not of Standard Quality (NSQ):

These drugs may meet some quality standards but do not meet the required standards,
potentially due to poor manufacturing practices or inadequate quality control.

 Adulterated Drugs:
These drugs contain substances that are not in the drug itself or are contaminated with
filth, rendering them unsafe for consumption.

The Central Drugs Standard Control Organisation (CDSCO) has identified counterfeit and
substandard medicines, raising concerns about public health. The CDSCO has issued alerts
about specific drugs, urging consumers to be vigilant and report suspicious medicines. Recent
reports have highlighted issues with drugs like Telma H and others, including those from
major pharmaceutical companies.

Key points about counterfeit and spurious medicines:

 CDSCO's role:

The CDSCO plays a crucial role in ensuring the quality and safety of drugs in the Indian
market, including detecting and addressing counterfeit and spurious medicines.

 Impact on public health:


Counterfeit and spurious drugs can pose serious health risks to consumers, as they may
contain incorrect dosages, harmful ingredients, or no active ingredients at all.

 Examples of flagged drugs:

Recent reports have highlighted various drugs, including those for high blood pressure,
diabetes, and other conditions, as being substandard or counterfeit.

 Retail market concerns:

There are growing concerns about the influx of counterfeit and spurious drugs in the
retail market, leading to potential harm to consumers.

 Measures to address the issue:

The CDSCO and other authorities are taking steps to combat the problem, including
issuing alerts, conducting investigations, and working with pharmaceutical companies to
enhance drug security.

 Consumer awareness:

Consumers are advised to be cautious when purchasing medicines, to check for proper
packaging, and to be aware of the possibility of counterfeit drugs.

 Importance of verification:

Consumers are encouraged to verify the authenticity of medicines, potentially through


QR codes or security features.

 Reporting suspected drugs:


Individuals can report any suspicious or substandard medicines to the CDSCO or the
relevant state authorities.

You might also like